Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis

Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatment. This work aims to develop a mannose receptor-targeted bioadhesive chitosan nanoparticles for effective drug-resistant tuberculosis treatment....

Full description

Saved in:
Bibliographic Details
Main Authors: Datta Maroti Pawde (Author), Matte Kasi Viswanadh (Author), Abhishesh Kumar Mehata (Author), Roshan Sonkar (Author), Narendra (Author), Suruchi Poddar (Author), Ankita Sanjay Burande (Author), Abhishek Jha (Author), Kiran Yellappa Vajanthri (Author), Sanjeev Kumar Mahto (Author), V.N. Azger Dustakeer (Author), Madaswamy S. Muthu (Author)
Format: Book
Published: Elsevier, 2020-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8111eb418b5b40a4a34a3d59680330a6
042 |a dc 
100 1 0 |a Datta Maroti Pawde  |e author 
700 1 0 |a Matte Kasi Viswanadh  |e author 
700 1 0 |a Abhishesh Kumar Mehata  |e author 
700 1 0 |a Roshan Sonkar  |e author 
700 1 0 |a  Narendra  |e author 
700 1 0 |a Suruchi Poddar  |e author 
700 1 0 |a Ankita Sanjay Burande  |e author 
700 1 0 |a Abhishek Jha  |e author 
700 1 0 |a Kiran Yellappa Vajanthri  |e author 
700 1 0 |a Sanjeev Kumar Mahto  |e author 
700 1 0 |a V.N. Azger Dustakeer  |e author 
700 1 0 |a Madaswamy S. Muthu  |e author 
245 0 0 |a Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis 
260 |b Elsevier,   |c 2020-12-01T00:00:00Z. 
500 |a 1319-0164 
500 |a 10.1016/j.jsps.2020.10.008 
520 |a Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatment. This work aims to develop a mannose receptor-targeted bioadhesive chitosan nanoparticles for effective drug-resistant tuberculosis treatment. The clofazimine loaded chitosan nanoparticles were formulated; their size, charge, polydispersity (PDI), surface morphology, entrapment efficiency (EE) and in-vitro release pattern were established. Also, cellular uptake study on C2C12 cell lines and anti-mycobacterial activity against H37Rv (a standard strain of Mycobacterium tuberculosis) were evaluated. The particle sizes of formulated chitosan nanoparticles were in the range of 132-184 nm and EE was also found to be between 73 and 95%. The functionalization of bioadhesive chitosan nanoparticles with mannose was confirmed by infrared spectroscopy (FTIR). The uptake studies on the C2C12 cell lines showed that mannosylated nanoparticles were more efficiently internalized when compared to non-targeted nanoparticles. Further, luciferase reporter phage (LRP) assay against H37Rv strain showed that clofazimine nanoparticles were found to be 49.5 times superior in terms of inhibition and anti-mycobacterial activity than free clofazimine. This excellent activity might be attributed to enhanced drug delivery with a promising bioadhesion property of chitosan-based nanoparticles. 
546 |a EN 
690 |a Chitosan 
690 |a Clofazimine 
690 |a Mannose receptor 
690 |a Nanoparticles 
690 |a Tuberculosis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1616-1625 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1319016420302437 
787 0 |n https://doaj.org/toc/1319-0164 
856 4 1 |u https://doaj.org/article/8111eb418b5b40a4a34a3d59680330a6  |z Connect to this object online.